These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 32778002)
1. Optimal diagnostic accuracy of quantitative faecal immunochemical test positivity thresholds for colorectal cancer detection in primary health care: A community-based cohort study. Pin-Vieito N; García Nimo L; Bujanda L; Román Alonso B; Gutierrez-Stampa MÁ; Aguilar-Gama V; Portillo I; Cubiella J United European Gastroenterol J; 2021 Mar; 9(2):256-267. PubMed ID: 32778002 [TBL] [Abstract][Full Text] [Related]
2. Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals. Grobbee EJ; Wisse PHA; Schreuders EH; van Roon A; van Dam L; Zauber AG; Lansdorp-Vogelaar I; Bramer W; Berhane S; Deeks JJ; Steyerberg EW; van Leerdam ME; Spaander MC; Kuipers EJ Cochrane Database Syst Rev; 2022 Jun; 6(6):CD009276. PubMed ID: 35665911 [TBL] [Abstract][Full Text] [Related]
3. High-risk symptoms and quantitative faecal immunochemical test accuracy: Systematic review and meta-analysis. Pin Vieito N; Zarraquiños S; Cubiella J World J Gastroenterol; 2019 May; 25(19):2383-2401. PubMed ID: 31148909 [TBL] [Abstract][Full Text] [Related]
4. Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study. Atkin W; Cross AJ; Kralj-Hans I; MacRae E; Piggott C; Pearson S; Wooldrage K; Brown J; Lucas F; Prendergast A; Marchevsky N; Patel B; Pack K; Howe R; Skrobanski H; Kerrison R; Swart N; Snowball J; Duffy SW; Morris S; von Wagner C; Halloran S Health Technol Assess; 2019 Jan; 23(1):1-84. PubMed ID: 30618357 [TBL] [Abstract][Full Text] [Related]
5. Understanding colorectal cancer risk for symptomatic patients in primary care: A cohort study utilising faecal immunochemical tests and blood results in England. Crooks CJ; Banerjea A; Jones J; Chapman C; Oliver S; West J; Humes DJ Aliment Pharmacol Ther; 2023 Aug; 58(4):443-452. PubMed ID: 37421214 [TBL] [Abstract][Full Text] [Related]
6. Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex? Arana-Arri E; Idigoras I; Uranga B; Pérez R; Irurzun A; Gutiérrez-Ibarluzea I; Fraser CG; Portillo I; BMC Cancer; 2017 Aug; 17(1):577. PubMed ID: 28851318 [TBL] [Abstract][Full Text] [Related]
7. Faecal haemoglobin concentration thresholds for reassurance and urgent investigation for colorectal cancer based on a faecal immunochemical test in symptomatic patients in primary care. Mowat C; Digby J; Strachan JA; McCann RK; Carey FA; Fraser CG; Steele RJ Ann Clin Biochem; 2021 May; 58(3):211-219. PubMed ID: 33334134 [TBL] [Abstract][Full Text] [Related]
8. Service evaluation of faecal immunochemical testing and anaemia for risk stratification in the 2-week-wait pathway for colorectal cancer. Chapman C; Bunce J; Oliver S; Ng O; Tangri A; Rogers R; Logan RF; Humes DJ; Banerjea A BJS Open; 2019 Jun; 3(3):395-402. PubMed ID: 31183456 [TBL] [Abstract][Full Text] [Related]
9. One or two faecal immunochemical tests in an organised population-based colorectal cancer screening programme in Murcia (Spain). Tourne-Garcia C; Perez-Riquelme F; Monteagudo-Piqueras O; Fraser CG; Yepes-Garcia P J Med Screen; 2022 Dec; 29(4):231-240. PubMed ID: 35578555 [TBL] [Abstract][Full Text] [Related]
10. Performance of two faecal immunochemical tests for the detection of advanced neoplasia at different positivity thresholds: a cross-sectional study of the Dutch national colorectal cancer screening programme. de Klerk CM; Wieten E; Lansdorp-Vogelaar I; Bossuyt PM; Spaander MC; Dekker E Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):111-118. PubMed ID: 30497962 [TBL] [Abstract][Full Text] [Related]
11. A comparison of the faecal haemoglobin concentrations and diagnostic accuracy in patients suspected with colorectal cancer and serious bowel disease as reported on four different faecal immunochemical test systems. Benton SC; Piggott C; Zahoor Z; O'Driscoll S; Fraser CG; D'Souza N; Chen M; Georgiou Delisle T; Abulafi M Clin Chem Lab Med; 2022 Jul; 60(8):1278-1286. PubMed ID: 35637625 [TBL] [Abstract][Full Text] [Related]
12. Do risk scores improve use of faecal immunochemical testing for haemoglobin in symptomatic patients in primary care? Digby J; Fraser CG; Clark G; Mowat C; Strachan JA; Steele RJC Colorectal Dis; 2024 Apr; 26(4):675-683. PubMed ID: 38424669 [TBL] [Abstract][Full Text] [Related]
13. 'Low' faecal immunochemical test (FIT) colorectal cancer: a 4-year comparison of the Nottingham '4F' protocol with FIT10 in symptomatic patients. Bailey JA; Morton AJ; Jones J; Chapman CJ; Oliver S; Morling JR; Patel H; Humes DJ; Banerjea A Colorectal Dis; 2024 Feb; 26(2):309-316. PubMed ID: 38173125 [TBL] [Abstract][Full Text] [Related]
14. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer. Digby J; Cleary S; Gray L; Datt P; Goudie DR; Steele RJC; Strachan JA; Humphries A; Fraser CG; Mowat C United European Gastroenterol J; 2020 Jun; 8(5):559-566. PubMed ID: 32213041 [TBL] [Abstract][Full Text] [Related]
16. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis. Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629 [TBL] [Abstract][Full Text] [Related]
17. Faecal immunochemical tests safely enhance rational use of resources during the assessment of suspected symptomatic colorectal cancer in primary care: systematic review and meta-analysis. Pin-Vieito N; Tejido-Sandoval C; de Vicente-Bielza N; Sánchez-Gómez C; Cubiella J Gut; 2022 May; 71(5):950-960. PubMed ID: 34108236 [TBL] [Abstract][Full Text] [Related]
18. Faecal immunochemical testing and blood tests for prioritization of urgent colorectal cancer referrals in symptomatic patients: a 2-year evaluation. Bailey JA; Weller J; Chapman CJ; Ford A; Hardy K; Oliver S; Morling JR; Simpson JA; Humes DJ; Banerjea A BJS Open; 2021 Mar; 5(2):. PubMed ID: 33693553 [TBL] [Abstract][Full Text] [Related]
19. Choice of faecal immunochemical test matters: comparison of OC-Sensor and HM-JACKarc, in the assessment of patients at high risk of colorectal cancer. Chapman CJ; Banerjea A; Humes DJ; Allen J; Oliver S; Ford A; Hardy K; Djedovic N; Logan RF; Morling JR Clin Chem Lab Med; 2021 Mar; 59(4):721-728. PubMed ID: 33112776 [TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England. Murphy J; Halloran S; Gray A BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]